Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) shares reached a new 52-week low on Wednesday . The company traded as low as $6.76 and last traded at $6.82, with a volume of 3020868 shares traded. The stock had previously closed at $7.12.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on the company. Piper Sandler cut their price target on Teladoc Health from $25.00 to $10.00 and set an “overweight” rating for the company in a research note on Tuesday, August 6th. DA Davidson dropped their price objective on Teladoc Health from $12.00 to $8.00 and set a “neutral” rating on the stock in a research note on Thursday, August 1st. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating for the company in a research note on Friday, August 2nd. Evercore ISI dropped their price target on shares of Teladoc Health from $14.00 to $10.00 and set an “in-line” rating on the stock in a research report on Tuesday, July 9th. Finally, Bank of America decreased their price objective on shares of Teladoc Health from $16.50 to $13.50 and set a “neutral” rating for the company in a research note on Tuesday, May 14th. Fourteen equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $12.44.
View Our Latest Analysis on Teladoc Health
Teladoc Health Stock Down 3.8 %
Teladoc Health (NYSE:TDOC – Get Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The health services provider reported ($0.28) EPS for the quarter, topping the consensus estimate of ($0.36) by $0.08. Teladoc Health had a negative return on equity of 10.25% and a negative net margin of 38.54%. The company had revenue of $642.44 million during the quarter, compared to analyst estimates of $649.34 million. On average, equities analysts predict that Teladoc Health, Inc. will post -0.7 earnings per share for the current year.
Insider Activity at Teladoc Health
In other news, insider Vidya Raman-Tangella sold 3,857 shares of Teladoc Health stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $31,395.98. Following the transaction, the insider now owns 33,667 shares in the company, valued at $274,049.38. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, insider Vidya Raman-Tangella sold 3,857 shares of the stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $31,395.98. Following the completion of the sale, the insider now owns 33,667 shares of the company’s stock, valued at $274,049.38. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, COO Michael Willem Waters sold 6,053 shares of Teladoc Health stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $49,271.42. Following the completion of the transaction, the chief operating officer now directly owns 74,214 shares in the company, valued at $604,101.96. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 42,880 shares of company stock valued at $355,689. Insiders own 0.95% of the company’s stock.
Institutional Trading of Teladoc Health
Large investors have recently added to or reduced their stakes in the stock. ICA Group Wealth Management LLC bought a new position in shares of Teladoc Health in the 4th quarter worth approximately $28,000. Signaturefd LLC grew its stake in Teladoc Health by 148.7% in the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after purchasing an additional 1,715 shares during the period. International Assets Investment Management LLC bought a new position in Teladoc Health in the second quarter worth $29,000. Hexagon Capital Partners LLC lifted its position in Teladoc Health by 204.4% during the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock valued at $34,000 after buying an additional 1,065 shares during the period. Finally, GAMMA Investing LLC bought a new stake in shares of Teladoc Health during the 4th quarter valued at $41,000. Institutional investors own 76.82% of the company’s stock.
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Read More
- Five stocks we like better than Teladoc Health
- Are Penny Stocks a Good Fit for Your Portfolio?
- BHP Stock: The Under-the-Radar Growth Story in Commodities
- How to Capture the Benefits of Dividend Increases
- Analysts Upgrade These 3 Hot Buy-and-Hold Stocks
- What is a Death Cross in Stocks?
- Kohl’s Charts a Resilient Path in a Challenging Retail Landscape
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.